Thanks to President Biden's leadership, drug manufacturers like Eli Lilly have followed suit and have voluntarily capped the price of insulin at $35 per month in the commercial market as well.
Carper highlights the impact of Biden's leadership on insulin pricing.
Share
More from Thomas R. Carper
I think that's really disgraceful, and it's unacceptable that the local DC courts have vacancies that last years because the Senate fails to act in a timely way.
Given how important this obviously is, my only regret is that we didn't have an opportunity to talk about it 24 hours ago.
You and our colleagues have heard me invoke in this room more times than I can count the Golden Rule: Treat other people the way I want to be treated.